Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
KYNB · NASDAQ · Pharmaceutical Preparations
$1.56−0.27 (−14.75%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Kyntra Bio (KYNB) · oqro.io/stocks/KYNB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded May 14, 2026 · Filed May 19, 2026
CEO purchased ~$20K of KYNB shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 18, 2025
CEO purchased ~$25K of KYNB shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 18, 2025
CEO purchased ~$9.2K of KYNB shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 2, 2025
Director purchased ~$119K of KYNB shares in the open marketSourceInsider trade · Traded Mar 24, 2025 · Filed Mar 25, 2025
CEO purchased ~$51K of KYNB shares in the open marketSourceInsider trade · Traded Mar 20, 2025 · Filed Mar 24, 2025
Director purchased ~$88K of KYNB shares in the open marketSourceInsider trade · Traded Mar 21, 2025 · Filed Mar 24, 2025
Director purchased ~$17K of KYNB shares in the open marketSource